Insider sale
ATARA BIOTHERAPEUTICS, INC.
$473.7K
80.55K shares
What this filing means
PANACEA INNOVATION LTD plans to sell 80.55K shares of ATARA BIOTHERAPEUTICS, INC. valued at approximately $473.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/12/2026ACC: 0001193125-26-010883
10% Owner
Since Mar 2026
80.55K
Shares to sell
$473.7K
Approx. market value
1.41M
Acquired (3 months)
3
Planned
Securities Acquired — Last 3 Months1
The Common Stock was purchased in multiple open market transactions from January 2025 through August 2025 as well as a registered direct financing in May 2025.
Cash
8/15/2025
1.41MTotal acquired1.41M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2025 | The Common Stock was purchased in multiple open market transactions from January 2025 through August 2025 as well as a registered direct financing in May 2025. Cash | 1.41M | — |
| Total | 1.41M | ||
Planned & Completed Dispositions3
NASDAQPlanned
Units to sell
20K
Market value
$117.6K
1/12/2026
NASDAQPlanned
Units to sell
40K
Market value
$235.2K
1/12/2026
NASDAQPlanned
Units to sell
20.55K
Market value
$120.9K
1/12/2026
Total
Units
80.55K
Value
$473.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/12/2026 | 20K | $117.6K | NASDAQ | Planned |
1/12/2026 | 40K | $235.2K | NASDAQ | Planned |
1/12/2026 | 20.55K | $120.9K | NASDAQ | Planned |
| Total | 80.55K | $473.7K | ||